Growth Metrics

Trulieve Cannabis (TCNNF) Gains from Sales and Divestitures (2021 - 2023)

Trulieve Cannabis has reported Gains from Sales and Divestitures over the past 3 years, most recently at $2.9 million for Q2 2023.

  • For Q2 2023, Gains from Sales and Divestitures rose 9392.95% year-over-year to $2.9 million; the TTM value through Jun 2023 reached $2.9 million, up 9392.95%, while the annual FY2022 figure was $163605.0, 94.4% down from the prior year.
  • Gains from Sales and Divestitures for Q2 2023 was $2.9 million at Trulieve Cannabis, roughly flat from $2.9 million in the prior quarter.
  • Over five years, Gains from Sales and Divestitures peaked at $2.9 million in Q4 2021 and troughed at $24444.0 in Q1 2022.
  • A 3-year average of $1.5 million and a median of $1.5 million in 2022 define the central range for Gains from Sales and Divestitures.
  • Biggest five-year swings in Gains from Sales and Divestitures: plummeted 98.43% in 2022 and later soared 11763.85% in 2023.
  • Year by year, Gains from Sales and Divestitures stood at $2.9 million in 2021, then crashed by 94.4% to $163605.0 in 2022, then surged by 1672.56% to $2.9 million in 2023.
  • Business Quant data shows Gains from Sales and Divestitures for TCNNF at $2.9 million in Q2 2023, $2.9 million in Q1 2023, and $163605.0 in Q4 2022.